187 related articles for article (PubMed ID: 35551547)
1. Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response.
Bohusné Barta B; Simon Á; Nagy L; Dankó T; Raffay RE; Petővári G; Zsiros V; Sebestyén A; Sipos F; Műzes G
PLoS One; 2022; 17(5):e0268217. PubMed ID: 35551547
[TBL] [Abstract][Full Text] [Related]
2. Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition
Sipos F; Bohusné Barta B; Simon Á; Nagy L; Dankó T; Raffay RE; Petővári G; Zsiros V; Wichmann B; Sebestyén A; Műzes G
Pathol Oncol Res; 2022; 28():1610322. PubMed ID: 35651701
[No Abstract] [Full Text] [Related]
3. Modified Genomic Self-DNA Influences In Vitro Survival of HT29 Tumor Cells via TLR9- and Autophagy Signaling.
Sipos F; Kiss AL; Constantinovits M; Tulassay Z; Műzes G
Pathol Oncol Res; 2019 Oct; 25(4):1505-1517. PubMed ID: 30465163
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells.
Fu J; Shi H; Cao N; Wu S; Zhan T; Xie L; Wang Z; Ye L; Li C; Shen Y; Yu C; Zheng L
Exp Cell Res; 2019 Feb; 375(2):51-59. PubMed ID: 30610847
[TBL] [Abstract][Full Text] [Related]
5. Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status.
Fűri I; Sipos F; Spisák S; Kiszner G; Wichmann B; Schöller A; Tulassay Z; Műzes G; Molnár B
ScientificWorldJournal; 2013; 2013():293296. PubMed ID: 24459426
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
Niu Z; Tang W; Liu T; Xu P; Zhu D; Ji M; Huang W; Ren L; Wei Y; Xu J
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1007-1017. PubMed ID: 30239551
[TBL] [Abstract][Full Text] [Related]
7. Ligand-based discovery of small molecules suppressing cancer cell proliferation via autophagic flux inhibition.
Liu L; Tian Z; Zhang Y; Liu P; Xin Z; Zhao Y; Li Y; Miao S; Shi J; Chen Z; Liu J; Zhang H
J Mol Med (Berl); 2020 Nov; 98(11):1573-1589. PubMed ID: 32897390
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA-induced alteration of autophagy response and TLR9-signaling: Their relation to amelioration of DSS-colitis.
Műzes G; Kiss AL; Tulassay Z; Sipos F
Comp Immunol Microbiol Infect Dis; 2017 Jun; 52():48-57. PubMed ID: 28673462
[TBL] [Abstract][Full Text] [Related]
9. Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells.
Ha HA; Chiang JH; Tsai FJ; Bau DT; Juan YN; Lo YH; Hour MJ; Yang JS
Oncol Rep; 2021 Feb; 45(2):680-692. PubMed ID: 33416156
[TBL] [Abstract][Full Text] [Related]
10. Calycosin induces apoptosis in adenocarcinoma HT29 cells by inducing cytotoxic autophagy mediated by SIRT1/AMPK-induced inhibition of Akt/mTOR.
El-Kott AF; Al-Kahtani MA; Shati AA
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):944-954. PubMed ID: 31276230
[TBL] [Abstract][Full Text] [Related]
11. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
[TBL] [Abstract][Full Text] [Related]
13. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
Koehler BC; Jassowicz A; Scherr AL; Lorenz S; Radhakrishnan P; Kautz N; Elssner C; Weiss J; Jaeger D; Schneider M; Schulze-Bergkamen H
BMC Cancer; 2015 Nov; 15():919. PubMed ID: 26585594
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer cells respond differentially to autophagy inhibition in vivo.
Lauzier A; Normandeau-Guimond J; Vaillancourt-Lavigueur V; Boivin V; Charbonneau M; Rivard N; Scott MS; Dubois CM; Jean S
Sci Rep; 2019 Aug; 9(1):11316. PubMed ID: 31383875
[TBL] [Abstract][Full Text] [Related]
15. Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.
Shahriari S; Rezaeifard S; Moghimi HR; Khorramizadeh MR; Faghih Z
Cancer Biomark; 2017; 18(4):375-380. PubMed ID: 28106541
[TBL] [Abstract][Full Text] [Related]
16. SPINK1 contributes to proliferation and clonal formation of HT29 cells through Beclin1 associated enhanced autophagy.
Hu NA; Zhang S; Jin A; Guo L; Qu Z; Wang J
Oncol Res; 2022; 30(2):89-97. PubMed ID: 37305325
[TBL] [Abstract][Full Text] [Related]
17. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
[TBL] [Abstract][Full Text] [Related]
18. AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells.
Seiwert N; Neitzel C; Stroh S; Frisan T; Audebert M; Toulany M; Kaina B; Fahrer J
Cell Death Dis; 2017 Aug; 8(8):e3019. PubMed ID: 28837154
[TBL] [Abstract][Full Text] [Related]
19. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy.
Anunobi R; Boone BA; Cheh N; Tang D; Kang R; Loux T; Lotze MT; Zeh HJ
J Surg Res; 2018 Jun; 226():181-191. PubMed ID: 29605400
[TBL] [Abstract][Full Text] [Related]
20. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.
Goulielmaki M; Koustas E; Moysidou E; Vlassi M; Sasazuki T; Shirasawa S; Zografos G; Oikonomou E; Pintzas A
Oncotarget; 2016 Feb; 7(8):9188-221. PubMed ID: 26802026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
